Financhill
Buy
57

ARCVF Quote, Financials, Valuation and Earnings

Last price:
$64.72
Seasonality move :
6.9%
Day range:
$64.72 - $64.72
52-week range:
$51.90 - $73.00
Dividend yield:
1.42%
P/E ratio:
--
P/S ratio:
1.41x
P/B ratio:
4.75x
Volume:
--
Avg. volume:
48
1-year change:
26.21%
Market cap:
$5.8B
Revenue:
$5.4B
EPS (TTM):
--
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3.9B $3.8B $4B $4.2B $5.4B
Revenue Growth (YoY) 1.15% -2.99% 5.97% 6.29% 27.48%
 
Cost of Revenues $1B $924.6M $963M $1.1B $1.3B
Gross Profit $2.9B $2.8B $3B $3.2B $4.1B
Gross Profit Margin 74.18% 75.49% 75.91% 74.93% 75.14%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $67.6M $58.4M $77.8M $92.6M $87.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.8B $2.6B $2.8B $2.9B $3.7B
Operating Income $107.8M $235.7M $273.4M $256.5M $322.6M
 
Net Interest Expenses $41.2M $29.5M $21.3M $21.6M $67.3M
EBT. Incl. Unusual Items $61.3M $83.6M $260.2M $200.8M $241M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $44.7M $62.9M $61.1M $62.7M $68.3M
Net Income to Company $16.6M $20.8M $199M $138.1M $172.7M
 
Minority Interest in Earnings -$2.9M $806.3K -$397.6K $562.1K $454.7K
Net Income to Common Excl Extra Items $13.8M $21.6M $198.6M $138.7M $173.2M
 
Basic EPS (Cont. Ops) $0.16 $0.24 $2.22 $1.55 $1.93
Diluted EPS (Cont. Ops) $0.16 $0.24 $2.21 $1.55 $1.93
Weighted Average Basic Share $88.4M $89.6M $89.4M $89.4M $89.8M
Weighted Average Diluted Share $89.1M $90.2M $89.8M $89.4M $89.8M
 
EBITDA $257.6M $274.7M $418.8M $363.7M $522M
EBIT $108.5M $117.3M $286.3M $230.7M $333.9M
 
Revenue (Reported) $3.9B $3.8B $4B $4.2B $5.4B
Operating Income (Reported) $107.8M $235.7M $273.4M $256.5M $322.6M
Operating Income (Adjusted) $108.5M $117.3M $286.3M $230.7M $333.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $1.1B
Revenue Growth (YoY) -- -- -- -- 33.2%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- $119.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- $90.1M
Weighted Average Diluted Share -- -- -- -- $90.1M
 
EBITDA -- -- -- -- $119.9M
EBIT -- -- -- -- $119.9M
 
Revenue (Reported) -- -- -- -- $1.1B
Operating Income (Reported) -- -- -- -- $119.9M
Operating Income (Adjusted) -- -- -- -- $119.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $3.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- $271.3M
 
Net Interest Expenses -- -- -- -- $21.7M
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- $345M
EBIT -- -- -- -- $292.5M
 
Revenue (Reported) -- -- -- -- $3.6B
Operating Income (Reported) -- -- -- -- $271.3M
Operating Income (Adjusted) -- -- -- -- $292.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $1.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- $119.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- $90.1M
Weighted Average Diluted Share -- -- -- -- $90.1M
 
EBITDA -- -- -- -- $119.9M
EBIT -- -- -- -- $119.9M
 
Revenue (Reported) -- -- -- -- $1.1B
Operating Income (Reported) -- -- -- -- $119.9M
Operating Income (Adjusted) -- -- -- -- $119.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $332.6M $526.4M $363M $260.8M $298.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $675.4M $576.2M $590.9M $782.4M $808.1M
Inventory $225.2K $308.7K $263.8K $284.2K $258.7K
Prepaid Expenses -- $73.2M $45.2M $61.8M $68.6M
Other Current Assets $57.6M -- -- -- --
Total Current Assets $1.8B $1.8B $1.7B $1.9B $2B
 
Property Plant And Equipment $410.8M $418.3M $352.7M $421.7M $387.9M
Long-Term Investments -- -- -- -- --
Goodwill $1.1B $961.4M $940.4M $1.4B $1.5B
Other Intangibles $87.1M $58.2M $40.3M $269M $206.6M
Other Long-Term Assets $30.9M $15.7M $12.7M $12.1M $11M
Total Assets $3.5B $3.3B $3.1B $4.1B $4.2B
 
Accounts Payable $825.4M $225.5M $262.9M $358.3M $345.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $84.8M $85.3M $70.8M $77.4M $77.8M
Other Current Liabilities -- $78.2M $61.7M $62.6M $87.2M
Total Current Liabilities $1.6B $1.4B $1.4B $1.7B $1.6B
 
Long-Term Debt $515.9M $493.2M $212.3M $967.2M $962.7M
Capital Leases -- -- -- -- --
Total Liabilities $2.4B $2.3B $1.9B $3.1B $3B
 
Common Stock $2M $2.2M $2M $1.9M $2M
Other Common Equity Adj -- -- -- -- --
Common Equity $1B $1.1B $1.2B $1.1B $1.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.2M -$1.5M -$1.3M -$2.2M -$2.6M
Total Equity $1B $1.1B $1.2B $1.1B $1.2B
 
Total Liabilities and Equity $3.5B $3.3B $3.1B $4.1B $4.2B
Cash and Short Terms $332.6M $526.4M $363M $260.8M $298.4M
Total Debt $684.7M $615.8M $298.5M $1B $974.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- --
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- --
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- --
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- --
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- --
 
Total Liabilities and Equity -- -- -- -- --
Cash and Short Terms -- -- -- -- --
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $16.6M $20.8M $199M $138.1M $172.7M
Depreciation & Amoritzation $149.2M $157.4M $132.6M $133M $188.1M
Stock-Based Compensation $12.9M $9.7M $6.9M $9M $6.7M
Change in Accounts Receivable -$5.2M $88.7M -$10.7M $5.8M -$66.7M
Change in Inventories $22.4K -$60.5K $21.3K -$33.8K $34.6K
Cash From Operations $243.8M $489.9M $389.8M $299.5M $334.2M
 
Capital Expenditures $54.3M $28.8M $41.2M $42.3M $43.9M
Cash Acquisitions -$27.8M -$65.1M -$5.4M -$842.5M $4.2M
Cash From Investing -$81.5M -$88.3M -$39.7M -$880.6M -$39.6M
 
Dividends Paid (Ex Special Dividend) -$21.3M -$4M -$37.2M -$122.6M -$71.7M
Special Dividend Paid
Long-Term Debt Issued $596.7M $298.9M $24.3M $994.3M $778M
Long-Term Debt Repaid -$578.2M -$405.4M -$306.9M -$320.8M -$872.5M
Repurchase of Common Stock -$15.2M -$9.1M -$91.5M -- --
Other Financing Activities -$7.2M $5.3M -$680.3K $3.5M -$13.4M
Cash From Financing -$96.9M -$199.4M -$486.1M $481.3M -$264.8M
 
Beginning Cash (CF) $269.4M $338.5M $531.1M $370.1M $278.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $65.3M $202.2M -$136M -$99.7M $29.8M
Ending Cash (CF) $331.8M $512.6M $415.2M $271.7M $302.6M
 
Levered Free Cash Flow $189.5M $461.2M $348.7M $257.2M $290.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- $7.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- $33.2M
Cash Acquisitions -- -- -- -- -$14.1M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$28.4M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- $624K -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock